BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28760534)

  • 21. [Adherence and Clinical Outcome of Sublingual Immunotherapy for Japanese Cedar Pollinosis].
    Yuta A; Ogawa Y; Suzuki Y; Arikata M; Kozaki H; Shimizu T; Ohta N
    Nihon Jibiinkoka Gakkai Kaiho; 2016 Dec; 119(12):1504-10. PubMed ID: 30035481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress.
    Yonekura S; Gotoh M; Okano M; Kurokawa T; Maekawa Y; Okubo K; Okamoto Y
    Allergol Int; 2022 Jan; 71(1):140-143. PubMed ID: 34509370
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis.
    Kikuoka H; Kouzaki H; Matsumoto K; Arai H; Yamamoto S; Tojima I; Shimizu S; Miyashita H; Ogawa Y; Osada T; Okano M; Yuta A; Shimizu T
    Clin Immunol; 2020 Jan; 210():108310. PubMed ID: 31743749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
    Fujii T; Kitamura Y; Kamimura S; Naito K; Takeda N
    Auris Nasus Larynx; 2021 Aug; 48(4):653-658. PubMed ID: 33461852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized double-blind comparative study of sublingual immunotherapy for cedar pollinosis.
    Okubo K; Gotoh M; Fujieda S; Okano M; Yoshida H; Morikawa H; Masuyama K; Okamoto Y; Kobayashi M
    Allergol Int; 2008 Sep; 57(3):265-75. PubMed ID: 18566549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
    Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
    Sakashita M; Yamada T; Imoto Y; Hirota T; Tamari M; Ito Y; Kubo S; Osawa Y; Takahashi N; Fujieda S
    Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of sublingual immunotherapy with tablets or drops containing Japanese cedar pollen antigens on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
    Fujii T; Kitamura Y; Kamimura S; Takeda N
    J Med Invest; 2022; 69(1.2):97-100. PubMed ID: 35466153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets.
    Yonekura S; Gotoh M; Kaneko S; Maekawa Y; Okubo K; Okamoto Y
    J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4103-4116.e14. PubMed ID: 34333190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enhanced Clinical Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis in the Second Year of Treatment].
    Yuta A; Ogawa Y; Suzuki Y; Arikata M; Kozaki H; Shimizu T; Ohta N
    Nihon Jibiinkoka Gakkai Kaiho; 2017 Jan; 120(1):44-51. PubMed ID: 30035467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [CLINICAL EFFICACY OF 69 PATIENTS WITH JAPANESE CEDAR POLLINOSIS TREATED BY SUBLINGUAL IMMUNOTHERAPY WITH CEDARCURE
    Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Kozaki H; Shimizu T
    Arerugi; 2019; 68(8):958-965. PubMed ID: 31534107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.
    Ott H; Sieber J; Brehler R; Fölster-Holst R; Kapp A; Klimek L; Pfaar O; Merk H
    Allergy; 2009 Jan; 64(1):179-86. PubMed ID: 19076534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis.
    Jerzynska J; Stelmach W; Rychlik B; Lechańska J; Podlecka D; Stelmach I
    Allergy Asthma Proc; 2016; 37(2):105-14. PubMed ID: 26932169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [ANALYSIS OF BACKGROUNDS AND LEVEL OF UNDERSTANDING OF TREATMENT OF POOR ADHERENCE AND DROPOUT CASES ON SUBLINGUAL IMMUNOTHERAPY FOR JAPANESE CEDAR POLLINOSIS IN THE FIRST FOLLOW-UP YEAR].
    Kikkawa S; Kamijo A; Nakagome K; Soma T; Kobayashi T; Uchida Y; Morita E; Nagata M; Inoue T; Kase Y
    Arerugi; 2017; 66(9):1165-1171. PubMed ID: 29129887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE SECOND TREATED YEAR FOR 133 PATIENTS WITH JAPANESE CEDAR POLLINOSIS IN 2016].
    Yuta A; Ogawa Y; Suzuki Y; Arikata M; Kozaki H; Shimizu T; Ohta N
    Arerugi; 2016; 65(9):1209-1218. PubMed ID: 27885205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis.
    Kurokawa T; Yonekura S; Gotoh M; Okano M; Maekawa Y; Okubo K; Okamoto Y
    J Allergy Clin Immunol Glob; 2023 May; 2(2):100075. PubMed ID: 37780797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.
    Ott H; Sieber J; Brehler R; Fölster-Holst R; Kapp A; Klimek L; Pfaar O; Merk H
    Allergy; 2009 Sep; 64(9):1394-401. PubMed ID: 19764942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a prospective, randomized, open-label study.
    Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
    Allergol Int; 2015 Apr; 64(2):161-8. PubMed ID: 25838092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of seasonal increase in serum interleukin-5 is linked to the clinical efficacy of immunotherapy for seasonal allergic rhinitis.
    Hayashi M; Ohashi Y; Tanaka A; Kakinoki Y; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():133-42. PubMed ID: 9879413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.